These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 176657)

  • 21. Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes.
    Davies TF; Teng CS; McLachlan SM; Smith BR; Hall R
    Mol Cell Endocrinol; 1978 Jan; 9(3):303-10. PubMed ID: 203502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance.
    Kuziemko GM; Stroh M; Stevens RC
    Biochemistry; 1996 May; 35(20):6375-84. PubMed ID: 8639583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gangliosides in acetylcholine receptor-rich membranes from Torpedo marmorata and Discopyge tschudii.
    Marcheselli V; Daniotti JL; Vidal AC; Maccioni H; Marsh D; Barrantes FJ
    Neurochem Res; 1993 May; 18(5):599-603. PubMed ID: 8474578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thyroid phospholipids on the interaction of thyrotropin with thyroid membranes.
    Omodeo-Sale F; Brady RO; Fishman PH
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5301-5. PubMed ID: 281681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of gangliosides in the interaction of a growth inhibitor with mouse LM cells.
    Bascom CC; Sharifi BG; Melkerson LJ; Rintoul DA; Johnson TC
    J Cell Physiol; 1985 Dec; 125(3):427-35. PubMed ID: 4066767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.
    Valente WA; Yavin Z; Yavin E; Grollman EF; Schneider M; Rotella CM; Zonefrati R; Toccafondi RS; Kohn LD
    J Endocrinol Invest; 1982; 5(5):293-301. PubMed ID: 6296219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane receptors for interferon.
    Besançon F; Ankel H
    Tex Rep Biol Med; 1977; 35():282-92. PubMed ID: 358455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.
    Bennett V; O'Keefe E; Cuatrecasaş P
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):33-7. PubMed ID: 164020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganglioside-cholera toxin interactions: a binding and lipid monolayer study.
    Cumar FA; Maggio B; Caputto R
    Mol Cell Biochem; 1982 Aug; 46(3):155-60. PubMed ID: 7121455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.
    Valente WA; Vitti P; Yavin Z; Yavin E; Rotella CM; Grollman EF; Toccafondi RS; Kohn LD
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6680-4. PubMed ID: 6292912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of cholera toxin and hormone receptors.
    Bennett V; Craig S; Hollenberg MD; O'Keefe E; Sahyoun N; Cuatrecasas P
    J Supramol Struct; 1976; 4(1):99-120. PubMed ID: 176537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of antiganglioside antibodies on thyrotrophin binding and adenyl cyclase activity of thyroid plasma membranes.
    Gardas A; Adler G; Lewartowska A; Faryna M; Nauman J
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):333-9. PubMed ID: 6314727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin receptors and gangliosides.
    Kohn LD; Consiglio E; DeWolf MJ; Grollman EF; Ledley FD; Lee G; Morris NP
    Adv Exp Med Biol; 1980; 125():487-503. PubMed ID: 6244725
    [No Abstract]   [Full Text] [Related]  

  • 34. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous gangliosides enhance the interaction of fibronectin with ganglioside-deficient cells.
    Yamada KM; Critchley DR; Fishman PH; Moss J
    Exp Cell Res; 1983 Feb; 143(2):295-302. PubMed ID: 6832218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes.
    Bolonkin D; Tate RL; Luber JH; Kohn LD; Winand RJ
    J Biol Chem; 1975 Aug; 250(16):6516-21. PubMed ID: 51021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quartz crystal microbalance investigation of the interaction of bacterial toxins with ganglioside containing solid supported membranes.
    Janshoff A; Steinem C; Sieber M; el Bayâ A; Schmidt MA; Galla HJ
    Eur Biophys J; 1997; 26(3):261-70. PubMed ID: 9273995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of carbohydrates in thyrotropin binding sites.
    Pekonen F
    Horm Metab Res; 1980 Jul; 12(7):310-4. PubMed ID: 6249706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific ganglioside changes in extraneural tissues of adult rats with hypothyroidism.
    Saito M; Sugiyama K
    Biochim Biophys Acta; 2000 Oct; 1523(2-3):230-5. PubMed ID: 11042389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides.
    Morris JC; McCormick DJ; Ryan RJ
    J Biol Chem; 1990 Feb; 265(4):1881-4. PubMed ID: 2298728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.